BSE - Delayed Quote INR

Vivo Bio Tech Limited (VIVOBIOT.BO)

Compare
36.35
+0.67
+(1.88%)
At close: 3:29:12 PM GMT+5:30
Loading Chart for VIVOBIOT.BO
  • Previous Close 35.68
  • Open 35.68
  • Bid 36.19 x --
  • Ask 36.49 x --
  • Day's Range 34.97 - 37.80
  • 52 Week Range 32.00 - 56.90
  • Volume 43,385
  • Avg. Volume 74,494
  • Market Cap (intraday) 623.94M
  • Beta (5Y Monthly) 0.67
  • PE Ratio (TTM) --
  • EPS (TTM) -1.87
  • Earnings Date May 19, 2025 - May 23, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, and analytical services. It also supplies SPF lab animals; breeds and distributes rodent models; and offers custom rodent models, and stem cell products, as well as lab animal diets. In addition, the company provides regulatory and non-regulatory IND preclinical services; screening and evaluating molecules for various pharmacological properties; and designs and develops of syngeneic / xenograft models for evaluation of anti-cancer agents evaluation. The company was formerly known as Sunshine Factors & Exports Limited and changed its name to Vivo Bio Tech Limited in September 2002. Vivo Bio Tech Limited was incorporated in 1987 and is based in Hyderabad, India.

www.vivobio.com

161

Full Time Employees

March 31

Fiscal Year Ends

Recent News: VIVOBIOT.BO

View More

Performance Overview: VIVOBIOT.BO

Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

VIVOBIOT.BO
2.10%
S&P BSE SENSEX (^BSESN)
1.40%

1-Year Return

VIVOBIOT.BO
5.07%
S&P BSE SENSEX (^BSESN)
5.62%

3-Year Return

VIVOBIOT.BO
5.07%
S&P BSE SENSEX (^BSESN)
32.06%

5-Year Return

VIVOBIOT.BO
5.07%
S&P BSE SENSEX (^BSESN)
151.76%

Compare To: VIVOBIOT.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VIVOBIOT.BO

View More

Valuation Measures

Annual
As of 4/15/2025
  • Market Cap

    612.44M

  • Enterprise Value

    1.18B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.25

  • Price/Book (mrq)

    1.02

  • Enterprise Value/Revenue

    2.55

  • Enterprise Value/EBITDA

    4.61

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.08%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    461.4M

  • Net Income Avi to Common (ttm)

    69.56M

  • Diluted EPS (ttm)

    -1.87

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.7M

  • Total Debt/Equity (mrq)

    96.79%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: VIVOBIOT.BO

View More

Company Insights: VIVOBIOT.BO

Research Reports: VIVOBIOT.BO

View More

People Also Watch